Johnson & Johnson’s Depuy Synthes has acquired CrossRoads Extremity Systems from HealpointCapital for an undisclosed sum.

UC Davis and Elon Musk's company Neuralink are facing allegations that researchers mistreated monkeys that were being used to test Neuralink's brain-machine interface technology.

FDA approval of Senseonics’ 6-month CGM system is just one many big milestones expected in the diabetes device space in 2022.

Dr. James Min, founder and CEO of Cleerly, joins us on this episode of Let’s Talk Medtech for a riveting discussion about cardiovascular disease during American Heart Month.

Aptar Pharma's HeroTracker Sense employs sensors to help coordinate inhalation with inhaler actuation, flow rate, and duration of use.

The Mountain View, CA-based company is going into the second phase of an IDE pivotal trial for the reSept ASD Occluder.

There’s a growing list of celebrities – including Mary J. Blige, Nick Jonas and Mandy Moore – putting medtech in the spotlight.

The first clinical study involving the Cysoni technology will begin later this year involving patients from hospitals in the UK, Australia, and New Zealand.

The VP of Medtronic's spine business talks about the shift from the age of the device to the age of the procedure in minimally invasive spine technologies.

Zimmer Biomet first announced it would spin off the dental and spine unit in February of 2021.